Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Verve Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit


Verve Therapeutics, a next-generation cardiovascular company, today announced that Sekar Kathiresan, M.D., co-founder and chief executive officer, will participate in the Jefferies Virtual Gene Therapy/Editing Summit being held October 1-2, 2020.

Dr. Kathiresan will present a corporate overview on Thursday, October 1, 2020, at 10:30 a.m. ET. During the presentation, Dr. Kathiresan will discuss Verve's approach to develop gene editing medicines to treat coronary heart disease, including recent preclinical progress in nonhuman primates demonstrating the successful use of base editing to precisely and efficiently edit targeted genes in the liver to lower levels of LDL cholesterol or triglycerides. Dr. Kathiresan will also cover upcoming development milestones and timelines.

In addition, Dr. Kathiresan will participate in a cardiovascular panel discussion on gene therapy on Thursday, October 1, 2020, at 2:00 p.m. ET. Verve will also hold one-on-one meetings at the summit.

About Verve Therapeutics

Verve Therapeutics is a biotechnology company created with a singular focus: to protect the world from heart disease. The company brings together human genetics analysis and gene editing ? two of the biggest breakthroughs in 21st century biomedicine ? to develop transformative therapies for coronary heart disease. Verve is developing medicines, administered once in life, to safely edit the genome of adults to permanently lower LDL cholesterol and triglyceride levels and thereby treat coronary heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, Verve is backed by a top-tier syndicate of investors, including GV (formerly Google Ventures), ARCH Venture Partners, F-Prime Capital, Biomatics Capital, Wellington Management, Casdin Capital, and Partners Innovation Fund. Verve is headquartered in Cambridge, Massachusetts. For more information, visit www.VerveTx.com.


These press releases may also interest you

at 19:30
Willow Biosciences Inc. ("Willow" or the "Company") , a leading biotechnology...

at 18:56
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:...

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...



News published on and distributed by: